Ingredient in GSK's HIV drugs linked to heart attacks

08/7/2008 | Bloomberg

Abacavir, an active ingredient in GlaxoSmithKline's HIV treatments Ziagen and Epzicom, is associated with a higher risk of heart attack in older patients, according to a Danish study. The findings support previous data that prompted GSK to add a warning to Ziagen's prescribing information last month.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX